España
India
Italia
대한민국
日本
My Account
Benzinga Edge
Benzinga Research
Benzinga Pro
Login
Get Benzinga Pro
Data & APIs
Events
Premarket
Boost
Advertise
Contribute
España
India
Italia
대한민국
日本
Login
Register
Our Services
News
Earnings
Guidance
Dividends
M&A
Buybacks
Legal
Interviews
Management
Offerings
IPOs
Insider Trades
Biotech/FDA
Politics
Healthcare
Markets
Pre-Market
After Hours
Movers
ETFs
Forex
Cannabis
Commodities
Binary Options
Bonds
Futures
CME Group
Global Economics
Mining
Previews
Small-Cap
Real Estate
Penny Stocks
Digital Securities
Volatility
Options
Ratings
Analyst Color
Downgrades
Upgrades
Initiations
Price Target
Ideas
Trade Ideas
Long Ideas
Short Ideas
Technicals
From The Press
Jim Cramer
Rumors
Whisper Index
Stock of the Day
Best Stocks & ETFs
Best Penny Stocks
Best S&P 500 ETFs
Best Swing Trade Stocks
Best Blue Chip Stocks
Best High-Volume Penny Stocks
Best Small Cap ETFs
Best Stocks to Day Trade
Best REITs
Money
Investing
Cryptocurrency
Mortgage
Insurance
Yield
Personal Finance
Forex
Startup Investing
Real Estate Investing
Prop Trading
Credit Cards
Stock Brokers
Crypto
News
Earnings
Guidance
Dividends
M&A
Buybacks
Legal
Interviews
Management
Offerings
IPOs
Insider Trades
Biotech/FDA
Politics
Healthcare
Markets
Pre-Market
After Hours
Movers
ETFs
Forex
Cannabis
Commodities
Binary Options
Bonds
Futures
CME Group
Global Economics
Mining
Previews
Small-Cap
Real Estate
Penny Stocks
Digital Securities
Volatility
Options
Ratings
Analyst Color
Downgrades
Upgrades
Initiations
Price Target
Ideas
Trade Ideas
Long Ideas
Short Ideas
Technicals
From The Press
Jim Cramer
Rumors
Whisper Index
Stock of the Day
Best Stocks & ETFs
Best Penny Stocks
Best S&P 500 ETFs
Best Swing Trade Stocks
Best Blue Chip Stocks
Best High-Volume Penny Stocks
Best Small Cap ETFs
Best Stocks to Day Trade
Best REITs
Money
Investing
Cryptocurrency
Mortgage
Insurance
Yield
Personal Finance
Forex
Startup Investing
Real Estate Investing
Prop Trading
Credit Cards
Stock Brokers
Crypto
Research
My Stocks
Tools
Free Benzinga Pro Trial
Calendars
Analyst Ratings Calendar
Conference Call Calendar
Dividend Calendar
Earnings Calendar
Economic Calendar
FDA Calendar
Guidance Calendar
IPO Calendar
M&A Calendar
SPAC Calendar
Stock Split Calendar
Trade Ideas
Free Stock Reports
Insider Trades
Trade Idea Feed
Analyst Ratings
Unusual Options Activity
Heatmaps
Free Newsletter
Government Trades
Perfect Stock Portfolio
Easy Income Portfolio
Short Interest
Most Shorted
Largest Increase
Largest Decrease
Calculators
Margin Calculator
Forex Profit Calculator
100x Options Profit Calculator
Recent
Markets
Comments
Close menu
Loading...
Vir Biotechnology
VIR
NASDAQ
Watchlist
Leave a Comment
Logo brought to you by Benzinga Data
Get Report
Perks
Buy
Compare Brokers
Get Report
Perks
Buy
Compare Brokers
$10.53
0.11
1.06%
At close: -
$10.53
0.00
0.00%
After Hours: 4:41 PM EDT
Get Report
Comment
Vir Biotechnology (VIR) Forecast
News
Earnings
Vir Biotechnology (VIR) Options
Guidance
Dividends
Analyst Ratings
Insider Trades
Short Interest
Latest news for Vir Biotechnology (NASDAQ:VIR) Stock
Vir Biotechnology Stock (NASDAQ: VIR)
Categories: All
All News
General
Contracts
Dividends
Events
FDA
M&A
Offerings
Stock Split
Media
Buybacks
Insider Trades
Earnings
Guidance
Analyst Ratings
Trading Ideas
All News
General
Contracts
Dividends
Events
FDA
M&A
Offerings
Stock Split
Media
Buybacks
Insider Trades
Earnings
Guidance
Analyst Ratings
Trading Ideas
Monday, January 13, 2025
Leerink Partners Maintains Outperform on Vir ...
Benzinga Newsdesk
Friday, January 10, 2025
Morgan Stanley Doubles Vir Biotechnology Price Forecast - Here's Why
Vandana Singh
HC Wainwright & Co. Reiterates Buy on Vir Bio...
Benzinga Newsdesk
Thursday, January 09, 2025
Morgan Stanley Upgrades Vir Biotechnology to ...
Benzinga Newsdesk
JP Morgan Maintains Neutral on Vir Biotechnol...
Benzinga Newsdesk
Wednesday, January 08, 2025
12 Health Care Stocks Moving In Wednesday's Pre-Market Session
Benzinga Insights
Vir Biotechnology Stock Soars On Prostate Cancer Trial Data - Here's Why
Vandana Singh
AAR Posts Upbeat Results, Joins AngioDynamics, eBay, Cal-Maine Foods And Other Big Stocks Moving Higher On Wednesday
Avi Kapoor
Vir Biotechnology shares are trading higher a...
Benzinga Newsdesk
Vir Biotechnology Is Presenting Initial Phase...
Lekha Gupta
Thursday, December 12, 2024
Vir Biotechnology Tobevibart And Elebsiran Re...
Benzinga Newsdesk
Tuesday, December 03, 2024
12 Health Care Stocks Moving In Tuesday's Pre-Market Session
Benzinga Insights
AT&T Updates 2024 Outlook, Joins ZJK Industrial, Janux Therapeutics, Credo Technology Group And Other Big Stocks Moving Higher On Tuesday
Avi Kapoor
Why Credo Technology Group Shares Are Trading Higher By 40%; Here Are 20 Stocks Moving Premarket
Avi Kapoor
Wednesday, November 20, 2024
HC Wainwright & Co. Reiterates Buy on Vir Bio...
Benzinga Newsdesk
Needham Reiterates Buy on Vir Biotechnology, ...
Benzinga Newsdesk
Tuesday, November 19, 2024
Reported Earlier, Vir Biotechnology Announces...
Benzinga Newsdesk
Monday, November 18, 2024
EMA Issued Opinion For Vir Biotechnology's Ap...
Benzinga Newsdesk
Friday, November 15, 2024
What's Going On With Liver Disease Focused Vir Biotechnology Stock Is Friday?
Vandana Singh
Vir Biotechnology Announces End-Of-Treatment ...
Benzinga Newsdesk
Monday, November 04, 2024
Barclays Maintains Overweight on Vir Biotechn...
Benzinga Newsdesk
HC Wainwright & Co. Reiterates Buy on Vir Bio...
Benzinga Newsdesk
Friday, November 01, 2024
Vir Biotechnology shares are trading higher. ...
Benzinga Newsdesk
Needham Reiterates Buy on Vir Biotechnology, ...
Benzinga Newsdesk
Thursday, October 31, 2024
Vir Biotechnology Q3 2024 Adj EPS $(1.56) Mis...
Benzinga Newsdesk
Wednesday, October 30, 2024
What's Next: Vir Biotechnology's Earnings Preview
Benzinga Insights
Tuesday, October 15, 2024
Vir Biotechnology Announces Clinical Advances...
Benzinga Newsdesk
Tuesday, September 10, 2024
Vir Biotechnology Appoints Jason O'Byrne As E...
Benzinga Newsdesk
Monday, September 09, 2024
Vir Biotechnology Announces Closing Of Exclus...
Benzinga Newsdesk
Tuesday, August 20, 2024
HC Wainwright & Co. Reiterates Buy on Vir Bio...
Benzinga Newsdesk
Friday, August 02, 2024
Breaking Down Vir Biotechnology: 6 Analysts Share Their Views
Benzinga Insights
Barclays Maintains Overweight on Vir Biotechn...
Benzinga Newsdesk
Thursday, August 01, 2024
Trading Halt: Halt status updated at 4:25:00 ...
Benzinga Newsdesk
Vir Biotechnology Lowers FY 2024 Operating Ex...
Benzinga Newsdesk
Vir Biotechnology Q2 2024 Adj EPS $(1.02) Mis...
Benzinga Newsdesk
Vir Biotechnology Enters Exclusive Worldwide ...
Benzinga Newsdesk
Trading Halt: Halted at 4:00:10 p.m. ET - Tra...
Benzinga Newsdesk
Wednesday, June 26, 2024
Vir Biotechnology's Hepatitis Delta Drug Comb...
Benzinga Newsdesk
Thursday, June 06, 2024
Morgan Stanley Maintains Equal-Weight on Vir ...
Benzinga Newsdesk
Wednesday, June 05, 2024
Why Is Infectious Disease-Focused Vir Biotechnology Stock Trading Higher On Wednesday?
Vandana Singh
Why Lands' End Shares Are Trading Lower? Here Are Other Stocks Moving In Wednesday's Mid-Day Session
Avi Kapoor
HC Wainwright & Co. Reiterates Buy on Vir Bio...
Benzinga Newsdesk
Needham Maintains Buy on Vir Biotechnology, R...
Benzinga Newsdesk
Ollie's Bargain Outlet Posts Upbeat Earnings, Joins Verint Systems, Guidewire Software And Other Big Stocks Moving Higher On Wednesday
Avi Kapoor
Vir Biotechnology shares are trading higher a...
Benzinga Newsdesk
Vir Biotechnology Announced New Preliminary D...
Benzinga Newsdesk
Friday, May 24, 2024
Evaluating Vir Biotechnology: Insights From 5 Financial Analysts
Benzinga Insights
HC Wainwright & Co. Reiterates Buy on Vir Bio...
Benzinga Newsdesk
Tuesday, May 21, 2024
Vir Biotechnology's SOLSTICE Data To Be Featu...
Benzinga Newsdesk
Tuesday, May 07, 2024
Deep Dive Into Vir Biotechnology Stock: Analyst Perspectives (6 Ratings)
Benzinga Insights
Show More
Create a Watchlist
FREE: Follow your stocks and cryptocurrencies with the most actionable alerts on the internet.
Click to Get Started
People Also Watch